IBANDRONAT Mepha 150 mg comprimés mensuels

7680613170036 CH-61317 M05BA06 07.99.0.

Reimbursement limitations:

BONVIVA

Pour le traitement de l'ostéoporose documentée.

IBANDRONAT Mepha 150 mg comprimés mensuels
IBANDRONAT Mepha 150 mg comprimés mensuels
IBANDRONAT Mepha 150 mg comprimés mensuels
1 / 3
google

Details

Product number
6131701
CPT
-
Packaging group
1
Unit
Tablette(n)
Composition
acidum ibandronicum 150 mg ut natrii ibandronas monohydricus, cellulosum microcristallinum, povidonum, crospovidonum, silica colloidalis anhydrica, acidum stearicum, Überzug: E 171, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 10.8 mg.

Articles (1)

Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
Filmtabletten
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/02/2021
Patient information leaflet
Français
08/02/2021
Patient information leaflet
Italien
08/02/2021
Professional SmPC
Allemand
08/02/2021
Professional SmPC
Français
08/02/2021

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
10.8 MG Substance HBESI

Reimbursement information

Public price
CHF 32.30
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2012

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
61317
Drug name
Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
Galenic form
FILM
ATC Code
M05BA06
Authorization status
Z
Dispensation category
B
First authorization
24/02/2011
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
IBANDRONAT Mepha 150 mg comprimés mensuels
Description (DE)
IBANDRONAT Mepha 150 mg Monatstabletten
Market launch
24/02/2011
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680574240014
CHF 210.75
View original

Other packaging sizes

IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce
3 TABL
GTIN: 7680613170043
View